ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Infectious Disease Rapid Diagnostic Testing Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-12N5912
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Infectious Disease Rapid Diagnostic Testing Market Insights Forecast to 2028
BUY CHAPTERS

Global Infectious Disease Rapid Diagnostic Testing Market Research Report 2025

Code: QYRE-Auto-12N5912
Report
June 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Abbott Laboratories
Roche
Danaher Corporation
Luminex Corporation
BGI Group
Biomerieux
DiaSorin
Hologic Inc
Mesa Biotech
Quidel Corporation
Thermo Fisher Scientific Inc
GenMark Diagnostics
CTK Biotech
Becton Dickinson
Cellex

Infectious Disease Rapid Diagnostic Testing Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Infectious Disease Rapid Diagnostic Testing Market

Infectious Disease Rapid Diagnostic Testing Market

The global market for Infectious Disease Rapid Diagnostic Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Infectious Disease Rapid Diagnostic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Disease Rapid Diagnostic Testing.
The Infectious Disease Rapid Diagnostic Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Infectious Disease Rapid Diagnostic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Infectious Disease Rapid Diagnostic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Infectious Disease Rapid Diagnostic Testing Market Report

Report Metric Details
Report Name Infectious Disease Rapid Diagnostic Testing Market
CAGR 5%
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott Laboratories, Roche Ltd, Danaher Corporation, Luminex Corporation, BGI Group, bioMerieux S.A., DiaSorin S.p.A, Hologic, Inc., Mesa Biotech, Quidel Corporation, Thermo Fisher Scientific Inc., GenMark Diagnostics, CTK Biotech, Becton Dickinson, Cellex Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Infectious Disease Rapid Diagnostic Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Infectious Disease Rapid Diagnostic Testing Market report?

Ans: The main players in the Infectious Disease Rapid Diagnostic Testing Market are Abbott Laboratories, Roche Ltd, Danaher Corporation, Luminex Corporation, BGI Group, bioMerieux S.A., DiaSorin S.p.A, Hologic, Inc., Mesa Biotech, Quidel Corporation, Thermo Fisher Scientific Inc., GenMark Diagnostics, CTK Biotech, Becton Dickinson, Cellex Inc.

What are the Application segmentation covered in the Infectious Disease Rapid Diagnostic Testing Market report?

Ans: The Applications covered in the Infectious Disease Rapid Diagnostic Testing Market report are Respiratory Infection, Gastro-Intestinal Infection, Center Nervous System Infection, Hospital Acquired Infection, Sexually Transmitted Infections, Others

What are the Type segmentation covered in the Infectious Disease Rapid Diagnostic Testing Market report?

Ans: The Types covered in the Infectious Disease Rapid Diagnostic Testing Market report are Assays, Platforms

Recommended Reports

Infectious Disease Diagnostics

Rapid and Point-of-Care Testing

Molecular And Clinical Testing

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infectious Disease Rapid Diagnostic Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Assays
1.2.3 Platforms
1.3 Market by Application
1.3.1 Global Infectious Disease Rapid Diagnostic Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Respiratory Infection
1.3.3 Gastro-Intestinal Infection
1.3.4 Center Nervous System Infection
1.3.5 Hospital Acquired Infection
1.3.6 Sexually Transmitted Infections
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Infectious Disease Rapid Diagnostic Testing Market Perspective (2020-2031)
2.2 Global Infectious Disease Rapid Diagnostic Testing Growth Trends by Region
2.2.1 Global Infectious Disease Rapid Diagnostic Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Infectious Disease Rapid Diagnostic Testing Historic Market Size by Region (2020-2025)
2.2.3 Infectious Disease Rapid Diagnostic Testing Forecasted Market Size by Region (2026-2031)
2.3 Infectious Disease Rapid Diagnostic Testing Market Dynamics
2.3.1 Infectious Disease Rapid Diagnostic Testing Industry Trends
2.3.2 Infectious Disease Rapid Diagnostic Testing Market Drivers
2.3.3 Infectious Disease Rapid Diagnostic Testing Market Challenges
2.3.4 Infectious Disease Rapid Diagnostic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infectious Disease Rapid Diagnostic Testing Players by Revenue
3.1.1 Global Top Infectious Disease Rapid Diagnostic Testing Players by Revenue (2020-2025)
3.1.2 Global Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Players (2020-2025)
3.2 Global Infectious Disease Rapid Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Infectious Disease Rapid Diagnostic Testing Revenue
3.4 Global Infectious Disease Rapid Diagnostic Testing Market Concentration Ratio
3.4.1 Global Infectious Disease Rapid Diagnostic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Rapid Diagnostic Testing Revenue in 2024
3.5 Global Key Players of Infectious Disease Rapid Diagnostic Testing Head office and Area Served
3.6 Global Key Players of Infectious Disease Rapid Diagnostic Testing, Product and Application
3.7 Global Key Players of Infectious Disease Rapid Diagnostic Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Infectious Disease Rapid Diagnostic Testing Breakdown Data by Type
4.1 Global Infectious Disease Rapid Diagnostic Testing Historic Market Size by Type (2020-2025)
4.2 Global Infectious Disease Rapid Diagnostic Testing Forecasted Market Size by Type (2026-2031)
5 Infectious Disease Rapid Diagnostic Testing Breakdown Data by Application
5.1 Global Infectious Disease Rapid Diagnostic Testing Historic Market Size by Application (2020-2025)
5.2 Global Infectious Disease Rapid Diagnostic Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Infectious Disease Rapid Diagnostic Testing Market Size (2020-2031)
6.2 North America Infectious Disease Rapid Diagnostic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Infectious Disease Rapid Diagnostic Testing Market Size by Country (2020-2025)
6.4 North America Infectious Disease Rapid Diagnostic Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Infectious Disease Rapid Diagnostic Testing Market Size (2020-2031)
7.2 Europe Infectious Disease Rapid Diagnostic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Infectious Disease Rapid Diagnostic Testing Market Size by Country (2020-2025)
7.4 Europe Infectious Disease Rapid Diagnostic Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Infectious Disease Rapid Diagnostic Testing Market Size (2020-2031)
8.2 Asia-Pacific Infectious Disease Rapid Diagnostic Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Infectious Disease Rapid Diagnostic Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Infectious Disease Rapid Diagnostic Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Infectious Disease Rapid Diagnostic Testing Market Size (2020-2031)
9.2 Latin America Infectious Disease Rapid Diagnostic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Infectious Disease Rapid Diagnostic Testing Market Size by Country (2020-2025)
9.4 Latin America Infectious Disease Rapid Diagnostic Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Size (2020-2031)
10.2 Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Infectious Disease Rapid Diagnostic Testing Introduction
11.1.4 Abbott Laboratories Revenue in Infectious Disease Rapid Diagnostic Testing Business (2020-2025)
11.1.5 Abbott Laboratories Recent Development
11.2 Roche Ltd
11.2.1 Roche Ltd Company Details
11.2.2 Roche Ltd Business Overview
11.2.3 Roche Ltd Infectious Disease Rapid Diagnostic Testing Introduction
11.2.4 Roche Ltd Revenue in Infectious Disease Rapid Diagnostic Testing Business (2020-2025)
11.2.5 Roche Ltd Recent Development
11.3 Danaher Corporation
11.3.1 Danaher Corporation Company Details
11.3.2 Danaher Corporation Business Overview
11.3.3 Danaher Corporation Infectious Disease Rapid Diagnostic Testing Introduction
11.3.4 Danaher Corporation Revenue in Infectious Disease Rapid Diagnostic Testing Business (2020-2025)
11.3.5 Danaher Corporation Recent Development
11.4 Luminex Corporation
11.4.1 Luminex Corporation Company Details
11.4.2 Luminex Corporation Business Overview
11.4.3 Luminex Corporation Infectious Disease Rapid Diagnostic Testing Introduction
11.4.4 Luminex Corporation Revenue in Infectious Disease Rapid Diagnostic Testing Business (2020-2025)
11.4.5 Luminex Corporation Recent Development
11.5 BGI Group
11.5.1 BGI Group Company Details
11.5.2 BGI Group Business Overview
11.5.3 BGI Group Infectious Disease Rapid Diagnostic Testing Introduction
11.5.4 BGI Group Revenue in Infectious Disease Rapid Diagnostic Testing Business (2020-2025)
11.5.5 BGI Group Recent Development
11.6 bioMerieux S.A.
11.6.1 bioMerieux S.A. Company Details
11.6.2 bioMerieux S.A. Business Overview
11.6.3 bioMerieux S.A. Infectious Disease Rapid Diagnostic Testing Introduction
11.6.4 bioMerieux S.A. Revenue in Infectious Disease Rapid Diagnostic Testing Business (2020-2025)
11.6.5 bioMerieux S.A. Recent Development
11.7 DiaSorin S.p.A
11.7.1 DiaSorin S.p.A Company Details
11.7.2 DiaSorin S.p.A Business Overview
11.7.3 DiaSorin S.p.A Infectious Disease Rapid Diagnostic Testing Introduction
11.7.4 DiaSorin S.p.A Revenue in Infectious Disease Rapid Diagnostic Testing Business (2020-2025)
11.7.5 DiaSorin S.p.A Recent Development
11.8 Hologic, Inc.
11.8.1 Hologic, Inc. Company Details
11.8.2 Hologic, Inc. Business Overview
11.8.3 Hologic, Inc. Infectious Disease Rapid Diagnostic Testing Introduction
11.8.4 Hologic, Inc. Revenue in Infectious Disease Rapid Diagnostic Testing Business (2020-2025)
11.8.5 Hologic, Inc. Recent Development
11.9 Mesa Biotech
11.9.1 Mesa Biotech Company Details
11.9.2 Mesa Biotech Business Overview
11.9.3 Mesa Biotech Infectious Disease Rapid Diagnostic Testing Introduction
11.9.4 Mesa Biotech Revenue in Infectious Disease Rapid Diagnostic Testing Business (2020-2025)
11.9.5 Mesa Biotech Recent Development
11.10 Quidel Corporation
11.10.1 Quidel Corporation Company Details
11.10.2 Quidel Corporation Business Overview
11.10.3 Quidel Corporation Infectious Disease Rapid Diagnostic Testing Introduction
11.10.4 Quidel Corporation Revenue in Infectious Disease Rapid Diagnostic Testing Business (2020-2025)
11.10.5 Quidel Corporation Recent Development
11.11 Thermo Fisher Scientific Inc.
11.11.1 Thermo Fisher Scientific Inc. Company Details
11.11.2 Thermo Fisher Scientific Inc. Business Overview
11.11.3 Thermo Fisher Scientific Inc. Infectious Disease Rapid Diagnostic Testing Introduction
11.11.4 Thermo Fisher Scientific Inc. Revenue in Infectious Disease Rapid Diagnostic Testing Business (2020-2025)
11.11.5 Thermo Fisher Scientific Inc. Recent Development
11.12 GenMark Diagnostics
11.12.1 GenMark Diagnostics Company Details
11.12.2 GenMark Diagnostics Business Overview
11.12.3 GenMark Diagnostics Infectious Disease Rapid Diagnostic Testing Introduction
11.12.4 GenMark Diagnostics Revenue in Infectious Disease Rapid Diagnostic Testing Business (2020-2025)
11.12.5 GenMark Diagnostics Recent Development
11.13 CTK Biotech
11.13.1 CTK Biotech Company Details
11.13.2 CTK Biotech Business Overview
11.13.3 CTK Biotech Infectious Disease Rapid Diagnostic Testing Introduction
11.13.4 CTK Biotech Revenue in Infectious Disease Rapid Diagnostic Testing Business (2020-2025)
11.13.5 CTK Biotech Recent Development
11.14 Becton Dickinson
11.14.1 Becton Dickinson Company Details
11.14.2 Becton Dickinson Business Overview
11.14.3 Becton Dickinson Infectious Disease Rapid Diagnostic Testing Introduction
11.14.4 Becton Dickinson Revenue in Infectious Disease Rapid Diagnostic Testing Business (2020-2025)
11.14.5 Becton Dickinson Recent Development
11.15 Cellex Inc.
11.15.1 Cellex Inc. Company Details
11.15.2 Cellex Inc. Business Overview
11.15.3 Cellex Inc. Infectious Disease Rapid Diagnostic Testing Introduction
11.15.4 Cellex Inc. Revenue in Infectious Disease Rapid Diagnostic Testing Business (2020-2025)
11.15.5 Cellex Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Abbott Laboratories
Roche
Danaher Corporation
Luminex Corporation
BGI Group
Biomerieux
DiaSorin
Hologic Inc
Mesa Biotech
Quidel Corporation
Thermo Fisher Scientific Inc
GenMark Diagnostics
CTK Biotech
Becton Dickinson
Cellex
List of Tables
 Table 1. Global Infectious Disease Rapid Diagnostic Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Assays
 Table 3. Key Players of Platforms
 Table 4. Global Infectious Disease Rapid Diagnostic Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Infectious Disease Rapid Diagnostic Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Infectious Disease Rapid Diagnostic Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Infectious Disease Rapid Diagnostic Testing Market Share by Region (2020-2025)
 Table 8. Global Infectious Disease Rapid Diagnostic Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Infectious Disease Rapid Diagnostic Testing Market Share by Region (2026-2031)
 Table 10. Infectious Disease Rapid Diagnostic Testing Market Trends
 Table 11. Infectious Disease Rapid Diagnostic Testing Market Drivers
 Table 12. Infectious Disease Rapid Diagnostic Testing Market Challenges
 Table 13. Infectious Disease Rapid Diagnostic Testing Market Restraints
 Table 14. Global Infectious Disease Rapid Diagnostic Testing Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Infectious Disease Rapid Diagnostic Testing Market Share by Players (2020-2025)
 Table 16. Global Top Infectious Disease Rapid Diagnostic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Rapid Diagnostic Testing as of 2024)
 Table 17. Ranking of Global Top Infectious Disease Rapid Diagnostic Testing Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Infectious Disease Rapid Diagnostic Testing Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Infectious Disease Rapid Diagnostic Testing, Headquarters and Area Served
 Table 20. Global Key Players of Infectious Disease Rapid Diagnostic Testing, Product and Application
 Table 21. Global Key Players of Infectious Disease Rapid Diagnostic Testing, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Infectious Disease Rapid Diagnostic Testing Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Type (2020-2025)
 Table 25. Global Infectious Disease Rapid Diagnostic Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Type (2026-2031)
 Table 27. Global Infectious Disease Rapid Diagnostic Testing Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Application (2020-2025)
 Table 29. Global Infectious Disease Rapid Diagnostic Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Application (2026-2031)
 Table 31. North America Infectious Disease Rapid Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Infectious Disease Rapid Diagnostic Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Infectious Disease Rapid Diagnostic Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Infectious Disease Rapid Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Infectious Disease Rapid Diagnostic Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Infectious Disease Rapid Diagnostic Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Infectious Disease Rapid Diagnostic Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Infectious Disease Rapid Diagnostic Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Infectious Disease Rapid Diagnostic Testing Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Infectious Disease Rapid Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Infectious Disease Rapid Diagnostic Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Infectious Disease Rapid Diagnostic Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Abbott Laboratories Company Details
 Table 47. Abbott Laboratories Business Overview
 Table 48. Abbott Laboratories Infectious Disease Rapid Diagnostic Testing Product
 Table 49. Abbott Laboratories Revenue in Infectious Disease Rapid Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 50. Abbott Laboratories Recent Development
 Table 51. Roche Ltd Company Details
 Table 52. Roche Ltd Business Overview
 Table 53. Roche Ltd Infectious Disease Rapid Diagnostic Testing Product
 Table 54. Roche Ltd Revenue in Infectious Disease Rapid Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 55. Roche Ltd Recent Development
 Table 56. Danaher Corporation Company Details
 Table 57. Danaher Corporation Business Overview
 Table 58. Danaher Corporation Infectious Disease Rapid Diagnostic Testing Product
 Table 59. Danaher Corporation Revenue in Infectious Disease Rapid Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 60. Danaher Corporation Recent Development
 Table 61. Luminex Corporation Company Details
 Table 62. Luminex Corporation Business Overview
 Table 63. Luminex Corporation Infectious Disease Rapid Diagnostic Testing Product
 Table 64. Luminex Corporation Revenue in Infectious Disease Rapid Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 65. Luminex Corporation Recent Development
 Table 66. BGI Group Company Details
 Table 67. BGI Group Business Overview
 Table 68. BGI Group Infectious Disease Rapid Diagnostic Testing Product
 Table 69. BGI Group Revenue in Infectious Disease Rapid Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 70. BGI Group Recent Development
 Table 71. bioMerieux S.A. Company Details
 Table 72. bioMerieux S.A. Business Overview
 Table 73. bioMerieux S.A. Infectious Disease Rapid Diagnostic Testing Product
 Table 74. bioMerieux S.A. Revenue in Infectious Disease Rapid Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 75. bioMerieux S.A. Recent Development
 Table 76. DiaSorin S.p.A Company Details
 Table 77. DiaSorin S.p.A Business Overview
 Table 78. DiaSorin S.p.A Infectious Disease Rapid Diagnostic Testing Product
 Table 79. DiaSorin S.p.A Revenue in Infectious Disease Rapid Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 80. DiaSorin S.p.A Recent Development
 Table 81. Hologic, Inc. Company Details
 Table 82. Hologic, Inc. Business Overview
 Table 83. Hologic, Inc. Infectious Disease Rapid Diagnostic Testing Product
 Table 84. Hologic, Inc. Revenue in Infectious Disease Rapid Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 85. Hologic, Inc. Recent Development
 Table 86. Mesa Biotech Company Details
 Table 87. Mesa Biotech Business Overview
 Table 88. Mesa Biotech Infectious Disease Rapid Diagnostic Testing Product
 Table 89. Mesa Biotech Revenue in Infectious Disease Rapid Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 90. Mesa Biotech Recent Development
 Table 91. Quidel Corporation Company Details
 Table 92. Quidel Corporation Business Overview
 Table 93. Quidel Corporation Infectious Disease Rapid Diagnostic Testing Product
 Table 94. Quidel Corporation Revenue in Infectious Disease Rapid Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 95. Quidel Corporation Recent Development
 Table 96. Thermo Fisher Scientific Inc. Company Details
 Table 97. Thermo Fisher Scientific Inc. Business Overview
 Table 98. Thermo Fisher Scientific Inc. Infectious Disease Rapid Diagnostic Testing Product
 Table 99. Thermo Fisher Scientific Inc. Revenue in Infectious Disease Rapid Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 100. Thermo Fisher Scientific Inc. Recent Development
 Table 101. GenMark Diagnostics Company Details
 Table 102. GenMark Diagnostics Business Overview
 Table 103. GenMark Diagnostics Infectious Disease Rapid Diagnostic Testing Product
 Table 104. GenMark Diagnostics Revenue in Infectious Disease Rapid Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 105. GenMark Diagnostics Recent Development
 Table 106. CTK Biotech Company Details
 Table 107. CTK Biotech Business Overview
 Table 108. CTK Biotech Infectious Disease Rapid Diagnostic Testing Product
 Table 109. CTK Biotech Revenue in Infectious Disease Rapid Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 110. CTK Biotech Recent Development
 Table 111. Becton Dickinson Company Details
 Table 112. Becton Dickinson Business Overview
 Table 113. Becton Dickinson Infectious Disease Rapid Diagnostic Testing Product
 Table 114. Becton Dickinson Revenue in Infectious Disease Rapid Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 115. Becton Dickinson Recent Development
 Table 116. Cellex Inc. Company Details
 Table 117. Cellex Inc. Business Overview
 Table 118. Cellex Inc. Infectious Disease Rapid Diagnostic Testing Product
 Table 119. Cellex Inc. Revenue in Infectious Disease Rapid Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 120. Cellex Inc. Recent Development
 Table 121. Research Programs/Design for This Report
 Table 122. Key Data Information from Secondary Sources
 Table 123. Key Data Information from Primary Sources
 Table 124. Authors List of This Report


List of Figures
 Figure 1. Infectious Disease Rapid Diagnostic Testing Picture
 Figure 2. Global Infectious Disease Rapid Diagnostic Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Infectious Disease Rapid Diagnostic Testing Market Share by Type: 2024 VS 2031
 Figure 4. Assays Features
 Figure 5. Platforms Features
 Figure 6. Global Infectious Disease Rapid Diagnostic Testing Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Infectious Disease Rapid Diagnostic Testing Market Share by Application: 2024 VS 2031
 Figure 8. Respiratory Infection Case Studies
 Figure 9. Gastro-Intestinal Infection Case Studies
 Figure 10. Center Nervous System Infection Case Studies
 Figure 11. Hospital Acquired Infection Case Studies
 Figure 12. Sexually Transmitted Infections Case Studies
 Figure 13. Others Case Studies
 Figure 14. Infectious Disease Rapid Diagnostic Testing Report Years Considered
 Figure 15. Global Infectious Disease Rapid Diagnostic Testing Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Infectious Disease Rapid Diagnostic Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Infectious Disease Rapid Diagnostic Testing Market Share by Region: 2024 VS 2031
 Figure 18. Global Infectious Disease Rapid Diagnostic Testing Market Share by Players in 2024
 Figure 19. Global Top Infectious Disease Rapid Diagnostic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Rapid Diagnostic Testing as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Infectious Disease Rapid Diagnostic Testing Revenue in 2024
 Figure 21. North America Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Infectious Disease Rapid Diagnostic Testing Market Share by Country (2020-2031)
 Figure 23. United States Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Infectious Disease Rapid Diagnostic Testing Market Share by Country (2020-2031)
 Figure 27. Germany Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Infectious Disease Rapid Diagnostic Testing Market Share by Region (2020-2031)
 Figure 35. China Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Infectious Disease Rapid Diagnostic Testing Market Share by Country (2020-2031)
 Figure 43. Mexico Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Share by Country (2020-2031)
 Figure 47. Turkey Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Abbott Laboratories Revenue Growth Rate in Infectious Disease Rapid Diagnostic Testing Business (2020-2025)
 Figure 51. Roche Ltd Revenue Growth Rate in Infectious Disease Rapid Diagnostic Testing Business (2020-2025)
 Figure 52. Danaher Corporation Revenue Growth Rate in Infectious Disease Rapid Diagnostic Testing Business (2020-2025)
 Figure 53. Luminex Corporation Revenue Growth Rate in Infectious Disease Rapid Diagnostic Testing Business (2020-2025)
 Figure 54. BGI Group Revenue Growth Rate in Infectious Disease Rapid Diagnostic Testing Business (2020-2025)
 Figure 55. bioMerieux S.A. Revenue Growth Rate in Infectious Disease Rapid Diagnostic Testing Business (2020-2025)
 Figure 56. DiaSorin S.p.A Revenue Growth Rate in Infectious Disease Rapid Diagnostic Testing Business (2020-2025)
 Figure 57. Hologic, Inc. Revenue Growth Rate in Infectious Disease Rapid Diagnostic Testing Business (2020-2025)
 Figure 58. Mesa Biotech Revenue Growth Rate in Infectious Disease Rapid Diagnostic Testing Business (2020-2025)
 Figure 59. Quidel Corporation Revenue Growth Rate in Infectious Disease Rapid Diagnostic Testing Business (2020-2025)
 Figure 60. Thermo Fisher Scientific Inc. Revenue Growth Rate in Infectious Disease Rapid Diagnostic Testing Business (2020-2025)
 Figure 61. GenMark Diagnostics Revenue Growth Rate in Infectious Disease Rapid Diagnostic Testing Business (2020-2025)
 Figure 62. CTK Biotech Revenue Growth Rate in Infectious Disease Rapid Diagnostic Testing Business (2020-2025)
 Figure 63. Becton Dickinson Revenue Growth Rate in Infectious Disease Rapid Diagnostic Testing Business (2020-2025)
 Figure 64. Cellex Inc. Revenue Growth Rate in Infectious Disease Rapid Diagnostic Testing Business (2020-2025)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Infectious Disease Rapid Diagnostic Testing Kits Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Rapid Virus Diagnostic Test Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Infectious Disease Diagnostic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Rapid Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Covid 19 Rapid Diagnostic Test Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Infectious Respiratory Disease Diagnostics Market Research Report 2025
Virus Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Infectious Diseases In Vitro Diagnostics Market Research Report 2024
Virus Testing Diagnostic Kits Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Infectious Disease In vitro Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Rapid Diagnostic Test RDTs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Point of Care Rapid Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti infectious Disease Drugs Market Research Report 2025
Global Hepatitis Viruses Diagnostic Tests Market Research Report 2024
Global Respiratory Infection Diagnostic Market Research Report 2024
Laboratory Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antibiotic Resistance Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Toxoplasmosis Diagnostic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Molecular Diagnostic Test Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Respiratory Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions